Top Food and Drug Cases, 2020, & Cases to Watch, 2021

Top Food and Drug Cases, 2020, & Cases to Watch, 2021 FDLI’s Top Food and Drug Cases is the companion volume to the popular panel at our Annual Conference. Become A Member As a general matter, “looking back at 2020” is a singularly unpleasant prospect for the vast majority [...]

Top Food and Drug Cases, 2020, & Cases to Watch, 20212022-06-30T14:08:18-04:00

AMG Capital Management, LLC v. Federal Trade Commission

AMG Capital Management, LLC v. Federal Trade Commission T. DANIEL LOGAN & JAQUELINE J. CHAN* Why It Made the List On first glance, a case about the Federal Trade Commission’s (FTC’s) remedies against payday lending may not appear relevant to food and drug law and its practitioners. However, in effect, many agencies pull enforcement [...]

AMG Capital Management, LLC v. Federal Trade Commission2022-06-29T11:13:00-04:00

Regenerative Medicine Conference Agenda

Why Attend Agenda CLE Tuesday, June 8 11:00–11:45 AM Bonus Session: A Primer on Regenerative Medicine Science and Recent Breakthroughs Heather C. Hatcher, Regulatory Scientist, Womble Bond Dickinson (US) LLP Collin Stabler, Senior Associate, Exponent, Inc. Moderated by Barbara A. Binzak Blumenfeld, Shareholder, Buchanan Ingersoll & Rooney PC [...]

Regenerative Medicine Conference Agenda2021-06-07T10:45:39-04:00

New, Emerging, and Continually Interesting Issues

New, Emerging, and Continually Interesting Issues Discuss emerging issues in transitional biologics, FDA protein definition, labeling carve-outs and carve-ins, authorized biosimilars, advertising and promotion draft guidance, purple book reform, and FDA’s umbrella policy for Reference Product (RP) exclusivity. Scott M. Lassman , Principal, Lassman Law + Policy SCOTT M. [...]

New, Emerging, and Continually Interesting Issues2022-04-04T10:52:02-04:00
Go to Top